An unusual case of cardiac amyloidosis

Research output: Contribution to journalArticle

Abstract

Cardiac amyloidosis can result from any of the systemic amyloidoses. The disease is often characterized by a restrictive cardiomyopathy although the particular signs and symptoms depend in part on the underlying cause. In addition to managing the symptoms of heart failure, treatment options vary depending on the etiology of amyloid deposition. It is therefore critical to identify the cause of cardiac amyloidosis before initiating definitive therapy. We present a patient with presumed immunoglobulin (AL) amyloidosis who had a circulating lambda monoclonal protein, but a bone marrow biopsy with kappa predominant plasma cells. This unusual finding called into question the diagnosis of AL amyloidosis and highlights the importance and difficulty of determining the cause of cardiac amyloid deposition before initiating treatment. We review the different forms of cardiac amyloidosis and propose a diagnostic algorithm to help identify the etiology of cardiac amyloid deposition before beginning therapy.

Original languageEnglish (US)
Pages (from-to)1047-1052
Number of pages6
JournalJournal of General Internal Medicine
Volume22
Issue number7
DOIs
StatePublished - Jul 2007

Fingerprint

Amyloidosis
Amyloid
Restrictive Cardiomyopathy
Therapeutics
Plasma Cells
Signs and Symptoms
Immunoglobulins
Heart Failure
Bone Marrow
Biopsy
Proteins

Keywords

  • AL amyloidosis
  • Cardiac amyloidosis
  • Familial amyloidosis
  • Restrictive cardiomyopathy

ASJC Scopus subject areas

  • Internal Medicine

Cite this

An unusual case of cardiac amyloidosis. / Garibaldi, Brian Thomas; Zaas, David.

In: Journal of General Internal Medicine, Vol. 22, No. 7, 07.2007, p. 1047-1052.

Research output: Contribution to journalArticle

@article{31ecb2f4008b4b328421f171c3e2a90e,
title = "An unusual case of cardiac amyloidosis",
abstract = "Cardiac amyloidosis can result from any of the systemic amyloidoses. The disease is often characterized by a restrictive cardiomyopathy although the particular signs and symptoms depend in part on the underlying cause. In addition to managing the symptoms of heart failure, treatment options vary depending on the etiology of amyloid deposition. It is therefore critical to identify the cause of cardiac amyloidosis before initiating definitive therapy. We present a patient with presumed immunoglobulin (AL) amyloidosis who had a circulating lambda monoclonal protein, but a bone marrow biopsy with kappa predominant plasma cells. This unusual finding called into question the diagnosis of AL amyloidosis and highlights the importance and difficulty of determining the cause of cardiac amyloid deposition before initiating treatment. We review the different forms of cardiac amyloidosis and propose a diagnostic algorithm to help identify the etiology of cardiac amyloid deposition before beginning therapy.",
keywords = "AL amyloidosis, Cardiac amyloidosis, Familial amyloidosis, Restrictive cardiomyopathy",
author = "Garibaldi, {Brian Thomas} and David Zaas",
year = "2007",
month = "7",
doi = "10.1007/s11606-007-0207-3",
language = "English (US)",
volume = "22",
pages = "1047--1052",
journal = "Journal of General Internal Medicine",
issn = "0884-8734",
publisher = "Springer New York",
number = "7",

}

TY - JOUR

T1 - An unusual case of cardiac amyloidosis

AU - Garibaldi, Brian Thomas

AU - Zaas, David

PY - 2007/7

Y1 - 2007/7

N2 - Cardiac amyloidosis can result from any of the systemic amyloidoses. The disease is often characterized by a restrictive cardiomyopathy although the particular signs and symptoms depend in part on the underlying cause. In addition to managing the symptoms of heart failure, treatment options vary depending on the etiology of amyloid deposition. It is therefore critical to identify the cause of cardiac amyloidosis before initiating definitive therapy. We present a patient with presumed immunoglobulin (AL) amyloidosis who had a circulating lambda monoclonal protein, but a bone marrow biopsy with kappa predominant plasma cells. This unusual finding called into question the diagnosis of AL amyloidosis and highlights the importance and difficulty of determining the cause of cardiac amyloid deposition before initiating treatment. We review the different forms of cardiac amyloidosis and propose a diagnostic algorithm to help identify the etiology of cardiac amyloid deposition before beginning therapy.

AB - Cardiac amyloidosis can result from any of the systemic amyloidoses. The disease is often characterized by a restrictive cardiomyopathy although the particular signs and symptoms depend in part on the underlying cause. In addition to managing the symptoms of heart failure, treatment options vary depending on the etiology of amyloid deposition. It is therefore critical to identify the cause of cardiac amyloidosis before initiating definitive therapy. We present a patient with presumed immunoglobulin (AL) amyloidosis who had a circulating lambda monoclonal protein, but a bone marrow biopsy with kappa predominant plasma cells. This unusual finding called into question the diagnosis of AL amyloidosis and highlights the importance and difficulty of determining the cause of cardiac amyloid deposition before initiating treatment. We review the different forms of cardiac amyloidosis and propose a diagnostic algorithm to help identify the etiology of cardiac amyloid deposition before beginning therapy.

KW - AL amyloidosis

KW - Cardiac amyloidosis

KW - Familial amyloidosis

KW - Restrictive cardiomyopathy

UR - http://www.scopus.com/inward/record.url?scp=34249937175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249937175&partnerID=8YFLogxK

U2 - 10.1007/s11606-007-0207-3

DO - 10.1007/s11606-007-0207-3

M3 - Article

C2 - 17447098

AN - SCOPUS:34249937175

VL - 22

SP - 1047

EP - 1052

JO - Journal of General Internal Medicine

JF - Journal of General Internal Medicine

SN - 0884-8734

IS - 7

ER -